Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Low Dose IGFBP1, IGFBP2 and ANGPTL3 Coordinately Stimulate Ex Vivo Expansion of Human Umbilical Cord Blood (UCB) Hematopoietic Stem Cells (HSCs).

Xiubo Fan, PhD, Pak Yan Chu, PhD, Florence Gay, BSc, Sudipto Bari, Justina Ang, SaiKiang Lim, PhD, William Hwang, MBBS, FRCP, FAMS

Blood (2010) 116 (21): 1546.

https://doi.org/10.1182/blood.V116.21.1546.1546

Published: 2010

Journal Articles

Kinetics of Engraftment and Graft Versus Host Disease After Cotransplantation of Ex Vivo Expanded and Unexpanded Cord Blood Units In Immunodeficient Mice.

Li Ming Ong, BSc, Xiubo Fan, PhD, Pak Yan Chu, PhD, Florence Gay, BSc, Justina Ang, BSc, Zhihong Li, Jianzhu Chen, PhD, SaiKiang Lim, PhD, Ralph Bunte, William Hwang, MBBS, FRCP, FAMS

Blood (2010) 116 (21): 3722.

https://doi.org/10.1182/blood.V116.21.3722.3722

Published: 2010

Journal Articles

Incorporation of Bortezomib Into Frontline Treatment of Multiple Myeloma According to Risk Stratification Shifts the Most Significant Prognostic Indicator From Cytogenetics to the Quality of Induction Response

Daryl Tan, MBBS, MRCP, Bernard K.C Yap, BSc, Lionel K.Y See, BSc, Grace Kam, MBBS, MRCP, Colin Phipps Diong, Yuh Shan Lee, MBBS, MRCP, Dawn Mya, MBBS, MRCP, William Hwang, MBBS, FRCP, FAMS, Yeow Tee Goh, MD

Blood (2010) 116 (21): 3056.

https://doi.org/10.1182/blood.V116.21.3056.3056

Published: 2010

Journal Articles

Targeting Isoprenylcysteine Carboxyl Methyltransferase to Overcome Resistance and Improve Responses in Chronic Myeloid Leukemia.

Wen Tian Sun, PhD, Bee Ling Ng, PhD, Li Yi Yang, BSc, Mei Wang, MD, PhD, William Hwang, MBBS, FRCP, Junia V. Melo, MD, PhD, Brian J. Druker, MD, Patrick J Casey, PhD, Charles Chuah, MBChB, MRCP, MD

Blood (2009) 114 (22): 3273.

https://doi.org/10.1182/blood.V114.22.3273.3273

Published: 2009

Journal Articles

Cytokine Induced Killer Cells Are Feasible and Safe for Both Autologous and Allogeneic Applications in Patients with Haematological Malignancies

Yeh Ching Linn, MD, Tsyr jong Lim, Madelaine Niam, Garnet Suck, PhD, Yeow Tee Goh, MD, William Hwang, Yvonne Loh, Lee Hui Ng, Hao Xiang Yong, Mickey Boon Chai Koh, MD, MRCP, MRCPath, PhD

Blood (2008) 112 (11): 2917.

https://doi.org/10.1182/blood.V112.11.2917.2917

Published: 2008

Journal Articles

The Haemophagocytic Syndrome Re-Visited: A Unique Asian Perspective.

Daryl C.L. Tan, MBBS, MRCP, Yvonne Loh, MBBS,MRCP, William Hwang, MBBS,MRCP, Y.C. Linn, MBBS,MRCP, G.C. Wong, MBBS,MRCP, L.C. Lim, MBBS,MRCP, L.H. Lee, MBBS,MMed, Y.T. Goh, MBBS,MMed, Mickey Koh, MBBS,MRCP,MRCPath

Blood (2006) 108 (11): 3840.

https://doi.org/10.1182/blood.V108.11.3840.3840

Published: 2006

Journal Articles

Outpatient-Based Therapy with Oral Fludarabine and Alemtuzumab for Asian Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL).

William Hwang, C. Dearden, S.M. Loh, Y.C. Linn, S.L. Tien, G. Teoh, L.F. Lim, P.X. Liew, G.F. How, K.K. Heng, Y.T. Goh, L.H. Lee

Blood (2006) 108 (11): 4992.

https://doi.org/10.1182/blood.V108.11.4992.4992

Published: 2006

Journal Articles

Use of Immunoglobulin Infusions in the Management of Bortezomib-Induced Peripheral Neuropathy in Multiple Myeloma.

Gerrard Teoh, MD, Daryl Tan, MD, William Hwang, MD, Liang Piu Koh, MD, Charles Chuah, MD, Heng Joo Ng, MD

Blood (2006) 108 (11): 5097.

https://doi.org/10.1182/blood.V108.11.5097.5097

Published: 2006

Journal Articles

Factors Influencing Responsiveness to Bortezomib in Patients with Multiple Myeloma Suggest a Possible Role for Host Immunocompetency.

Gerrard Teoh, MD, Daryl Tan, MD, William Hwang, MD, Liang Piu Koh, MD, Charles Chuah, MD, Heng Joo Ng, MD

Blood (2006) 108 (11): 5100.

https://doi.org/10.1182/blood.V108.11.5100.5100

Published: 2006

Journal Articles

High Response and Complete Remission Rates in Relapsed/Refractory Multiple Myeloma Treated with Bortezomib, Thalidomide, Dexamethasone and Zoledronic Acid (VTD-Z) Combination Therapy.

Gerrard Teoh, MD, Daryl Tan, MD, William Hwang, MD, Liang Piu Koh, MD, Charles Chuah, MD, Heng Joo Ng, MD

Blood (2005) 106 (11): 5127.

https://doi.org/10.1182/blood.V106.11.5127.5127

Published: 2005

Journal Articles

Low Dose Dexamethasone and Thalidomide with Higher Frequency Zoledronic Acid (dtZ) for Multiple Myeloma.

Gerrard Teoh, MD, William Hwang, MD, Liang Piu Koh, MD, Mickey Koh, MD, Daryl Tan, MD, Charles Gullo, PhD

Blood (2004) 104 (11): 4915.

https://doi.org/10.1182/blood.V104.11.4915.4915

Published: 2004

Journal Articles

Decoupling of Normal CD40 / Interleukin-4 Immunoglobulin Heavy Chain Switch Signal Leads to Genomic Instability in RPMI 8226 and SGH-MM5 Multiple Myeloma Cell Lines.

William Hwang, MD, Charles Gullo, PhD, Gerrard Teoh, MD

Blood (2004) 104 (11): 1424.

https://doi.org/10.1182/blood.V104.11.1424.1424

Published: 2004

Journal Articles

CD40 Ligand Stimulation of Multiple Myeloma Cells Results in Upregulation of Surface Expressed Heat Shock Proteins and Increased Antigenicity.

Charles A. Gullo, William Hwang, Melvin Au, Edward A. Greenfield, Kenneth C. Anderson, Gerrard Teoh

Blood (2004) 104 (11): 3351.

https://doi.org/10.1182/blood.V104.11.3351.3351

Published: 2004

NARROW

Low Dose IGFBP1, IGFBP2 and ANGPTL3 Coordinately Stimulate Ex Vivo Expansion of Human Umbilical Cord Blood (UCB) Hematopoietic Stem Cells (HSCs).

Kinetics of Engraftment and Graft Versus Host Disease After Cotransplantation of Ex Vivo Expanded and Unexpanded Cord Blood Units In Immunodeficient Mice.

Incorporation of Bortezomib Into Frontline Treatment of Multiple Myeloma According to Risk Stratification Shifts the Most Significant Prognostic Indicator From Cytogenetics to the Quality of Induction Response

Targeting Isoprenylcysteine Carboxyl Methyltransferase to Overcome Resistance and Improve Responses in Chronic Myeloid Leukemia.

Cytokine Induced Killer Cells Are Feasible and Safe for Both Autologous and Allogeneic Applications in Patients with Haematological Malignancies

The Haemophagocytic Syndrome Re-Visited: A Unique Asian Perspective.

Outpatient-Based Therapy with Oral Fludarabine and Alemtuzumab for Asian Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL).

Use of Immunoglobulin Infusions in the Management of Bortezomib-Induced Peripheral Neuropathy in Multiple Myeloma.

Factors Influencing Responsiveness to Bortezomib in Patients with Multiple Myeloma Suggest a Possible Role for Host Immunocompetency.

High Response and Complete Remission Rates in Relapsed/Refractory Multiple Myeloma Treated with Bortezomib, Thalidomide, Dexamethasone and Zoledronic Acid (VTD-Z) Combination Therapy.

Low Dose Dexamethasone and Thalidomide with Higher Frequency Zoledronic Acid (dtZ) for Multiple Myeloma.

Decoupling of Normal CD40 / Interleukin-4 Immunoglobulin Heavy Chain Switch Signal Leads to Genomic Instability in RPMI 8226 and SGH-MM5 Multiple Myeloma Cell Lines.

CD40 Ligand Stimulation of Multiple Myeloma Cells Results in Upregulation of Surface Expressed Heat Shock Proteins and Increased Antigenicity.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only